Figure (Um Logo)
Forteo Injection, Solution
Product Images NDC 0002-8400
24 FDA label images from Eli Lilly And Company · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Forteo (NDC 0002-8400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Molecular Weight Of Teriparatide (Forteo F001 V01)
Chemical structure of Teriparatide depicted as a linear sequence of amino acids numbered 1 through 34, representing the peptide composition of the active ingredient in Forteo injection solution.*
Figure 1 (Forteo F002 V01)
A line graph comparing the percentage of patients with nonvertebral osteoporotic fractures over 20 months since randomization between Forteo and placebo groups. The vertical axis shows the percent of patients with fractures, ranging from 0 to 8%. The Forteo group is represented by a dotted line, consistently showing a lower percentage of fractures compared to the placebo group, indicated by a solid line.*
Forteo Pen Carton 20mcg 002 06
Forteo teriparatide injection 250 mcg/mL subcutaneous solution packaging label. The label indicates a 20 mcg dose given once daily, with a single-use prefilled pen delivering 28 doses totaling 600 mcg/2.4 mL. Instructions emphasize not transferring contents to a syringe, refrigeration required, and no needle inclusion. Manufactured by Eli Lilly and Company.*
Figure (Forteo Um Arrow V1)
Figure (Forteo Um F01 V2)
Illustration diagram of the FORTEO delivery device parts, showing labeled components including the black injection button, yellow shaft, red stripe, blue body, label, medicine cartridge, white cap, paper tab, needle, small needle protector, and large needle cover. Note indicates needles are not included, and specific pen needles are recommended for use with this device.*
Figure (Forteo Um F02 V1)
An instructional illustration showing hands removing a gray cap from a blue pen-style injection device, likely demonstrating preparation for subcutaneous injection.*
Figure (Forteo Um F03 V1)
An instructional illustration showing hands removing a protective cap from a small vial or pen device, likely related to preparing a subcutaneous injection.*
Figure (Forteo Um F04 V1)
An instructional illustration showing hands preparing a subcutaneous injection pen device. One hand holds the injection pen, while the other hand is placing or removing a needle cover, demonstrating the steps to ready the device for injection.*
Figure (Forteo Um F05 V1)
Instructional illustration showing hands preparing a Forteo (Teriparatide) 250 mcg/mL subcutaneous injection pen. The image depicts removing a protective cap from the pen prior to administration.*
Figure (Forteo Um F06 V1)
An instructional illustration showing a large needle cover being removed from a prefilled syringe. The image highlights the needle area and the hand gripping the cover, indicating needle preparation for injection.*
Figure (Forteo Um F07 V1)
An instructional illustration showing a person holding and preparing a Forteo injection pen for subcutaneous administration. The image depicts the hand gripping the pen device and the other hand removing the protective cap from the pen's needle end, indicated by a downward arrow.*
Figure (Forteo Um F08 V1)
An instructional diagram showing a hand holding a small vial marked with a red stripe, highlighting the vial's identification feature for proper use. The focus is a close-up view of the vial held between fingers.*
Figure (Forteo Um F09 V1)
An instructional diagram showing a hand removing a small needle protector from a syringe tip. The image highlights the small needle protector as part of an injection device process.*
Figure (Forteo Um F10 V1)
An instructional illustration showing a person administering a subcutaneous injection in the abdominal area using an injection pen device. The image emphasizes proper hand positioning and injection site for subcutaneous administration.*
Figure (Forteo Um F11 V1)
An instructional illustration showing a hand holding an injection pen device aimed at the abdomen, demonstrating subcutaneous injection technique. Numbers 1 to 5 appear below, likely indicating step-by-step instructions or countdown during injection. This image is relevant for subcutaneous administration of Forteo (Teriparatide) injection.*
Figure (Forteo Um F12 V1)
An instructional illustration showing a close-up of a hand gripping the top part of an injection device or pen, with a blue highlight circle emphasizing the thumb position on the cap or button.*
Figure (Forteo Um F13 V1)
An instructional illustration showing a hand holding an injection pen with a red prohibition symbol over it, indicating that the action of holding the injection pen in that manner is not recommended or should be avoided.*
Figure (Forteo Um F14 V1)
An instructional illustration showing a hand holding a Forteo (teriparatide) injection pen, demonstrating the removal of the large needle cover prior to subcutaneous injection.*
Figure (Forteo Um F15 V1)
Illustration depicting hands removing or attaching a cap from a pen injection device, likely related to administration of a subcutaneous injection such as Forteo (Teriparatide) 250 mcg/mL solution by Eli Lilly and Company.*
Figure (Forteo Um F16 V1)
An instructional illustration showing a person holding a Forteo (teriparatide) injection pen device. The image depicts the action of removing the blue protective cap from the pen, preparing it for subcutaneous administration.*
Figure (Forteo Um F17 V1)
An instructional illustration showing a hand removing the protective cap from a prefilled injection pen, likely for the subcutaneous injection of Forteo (teriparatide) 250 mcg/mL solution by Eli Lilly and Company.*
Figure (Forteo Um F18 V1)
Forteo 250 mcg/mL injection, solution pen for subcutaneous use by Eli Lilly and Company. The image shows a prefilled injection pen device with a blue and white label, designed for delivering the prescription medication Teriparatide.*
Figure (Forteo Um F19 V1)
An instructional illustration showing a person holding a pen-style device with a red prohibition symbol overlay, indicating not to perform a specific action with the device. The image focuses on the thumb and fingers gripping the device, commonly used for subcutaneous injection administration.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
